Purdue Pharma has appointed Dr Alan Dunton as senior vice president of research and development in a role that also sees him join its executive committee.
Dr Dunton will serve as the company’s lead scientist and oversee medical research, drug safety, clinical pharmacology, virtual discovery, project management, and pharmaceutics and analytics teams.
He will report to chief executive officer Mark Timney who said: “At a time of transformation for Purdue, Alan brings the right skills and
experience to diversify and grow our portfolio.”
Dr Dunton has spent 33 years in the industry discovering and developing new prescription and over-the-counter products. In 2006, he
founded Danerius, a biotechnology and pharmaceutical consulting business, which he led until joining Purdue.
Prior to starting Danerius, Dr. Dunton held executive-level positions in the pharmaceutical and biotechnology industries, including President and Chief Executive Officer of Panacos Pharmaceuticals and Metaphore Pharmaceuticals.
He was also the president and managing director of the Janssen Research Foundation, the R&D arm of the pharmaceuticals division at Johnson & Johnson.